发明名称 Long term drug delivery devices with polyurethane-based polymers and their manufacture
摘要 This invention is related to the use of polyurethane-based polymer as a drug delivery device to deliver biologically active compounds at a constant rate for an extended period of time and methods of manufactures thereof. The device is very biocompatible and biostable, and is useful as an implant in patients (humans and animals) for the delivery of appropriate bioactive substances to tissues or organs.
申请公布号 US8784865(B2) 申请公布日期 2014.07.22
申请号 US201313892946 申请日期 2013.05.13
申请人 Endo Pharmaceuticals Solutions Inc. 发明人 Kuzma Petr;Quandt Harry
分类号 A61F2/00;A61K9/00 主分类号 A61F2/00
代理机构 RatnerPrestia 代理人 RatnerPrestia
主权项 1. An implantable drug delivery device, comprising a polyurethane-based polymer having polyether-based polyol segments represented by the formula —[O—(CH2)n]x—O—, said polyurethane-based polymer configured to provide a cylindrically shaped reservoir, wherein the reservoir is sealed after being charged with an effective amount of solid formulation comprising an active agent and one or more pharmaceutically acceptable carriers, such that the release of the active agent at a substantially zero order rate in vitro by diffusion through the polyurethane-based polymer generally increases as the equilibrium water content (% EWC) of the polymer increases, wherein the active agent is histrelin, risperidone, dexamethasone, naltrexone, metolazone, clonidine, or selegiline.
地址 Malvern PA US